Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Published Date: 08 Dec 2023

Treatment-sensitive patients may benefit most from ongoing care, according to an expert.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Base-edited T-cell therapy offers additional hope for treating resistant leukemia.

2.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

3.

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

4.

Using MRD Status to Deescalate Multiple Myeloma Therapy

5.

Sydney researchers identify new tools to improve cancer diagnosis and treatment.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot